Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Granisetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 14 Nausea 11 Neoplasms 3 Lymphoma 3 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Leukemia 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Solid Tumours 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Docetaxel 148 Prednisone 118 Leuprolide 84 enzalutamide 74 Radiotherapy 73 bicalutamide 72 Abiraterone Acetate 69 Goserelin 66 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 50 Zoledronic Acid 37 Magnetic Resonance Spectroscopy 37 Estramustine 30 gallium 68 PSMA-11 29 Flutamide 28 apalutamide 27 abiraterone 27 radium Ra 223 dichloride 25 cabazitaxel 22 Radiosurgery 22 Gonadotropin-Releasing Hormone 22 Androgen Antagonists 21 Surveys and Questionnaires 20 Dutasteride 20 sipuleucel-T 19 Paclitaxel 19 Radiation 18 Prednisolone 18 Exercise 18 Triptorelin Pamoate 17 Mitoxantrone 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02441894 2017-01-24

PEGAZUS

Sanofi

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡